[Form 4] Synergy CHC Corp. Insider Trading Activity
Rhea-AI Filing Summary
Synergy CHC Corp. director and president Alfred Baumeler re-priced a stock option award covering 150,000 shares of common stock. On this Form 4, a prior option for 150,000 shares with a $2.38 per share exercise price was canceled and a new option for 150,000 shares with a $0.21 per share exercise price was granted in its place.
According to the footnotes, this reduction in exercise price is treated under Section 16 as a cancellation and re-grant of the same award. The new option vests on the same schedule as the original option, with one-third vesting on the first anniversary of September 18, 2025 and the remaining two-thirds vesting in equal monthly installments over the following 24 months, subject to continued service. The new option expires on the five-year anniversary of the original grant date. These are compensation-related derivative transactions, with no reported open-market purchases or sales of common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 150,000 | $0.00 | -- |
| Disposition | Stock Option (right to buy) | 150,000 | $0.00 | -- |
Footnotes (1)
- One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company. The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.